Skip to main content

Advertisement

Log in

Spectral domain optical coherence tomography imaging of mucopolysaccharidoses I, II, and VI A

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to describe the spectral domain optical coherence tomography (SD-OCT) characteristics of patients with retinal manifestations of mucopolysaccharidoses (MPSs) I, II, and IV A.

Design

The research was a prospective, observational study.

Methods

Fourteen consecutive patients with variants of MPS and 15 healthy subjects underwent ophthalmic assessments including fundus examinations and SD-OCT.

Results

The fundus examinations revealed that four patients (two MPS I and two MPS II) had pigmented retinopathy in both eyes. In addition, one MPS II patient had cystoid macular edema and two MPS II patients had abnormal disc morphology. SD-OCT revealed thinning of the parafoveal photoreceptor inner segment/outer segment (IS/OS; two MPS I and one MPS II) and perifoveal photoreceptor IS/OS (two MPS I and five MPS II). All MPS I and II patients exhibited thickening of the central foveal external limiting membrane (ELM). Fundus and SD-OCT findings were normal in MPS IV A and healthy subjects. The foveal ELM was significantly thicker in MPS I and II patients than in healthy subjects (P =0 .000 and P =0 .000, respectively). The foveal IS/OS was significantly thinner in MPS I, II, and IV A patients than in healthy subjects (P = 0.000, P = 0.000, and P = 0.030, respectively). The foveal retinal pigment epithelium layer was also thinner in MPS II patients than in healthy subjects (P = 0.007)

Conclusions

In MPS, accumulation of glycosaminoglycans in retinal tissue induced retinal degeneration and pigmentary retinopathy. SD-OCT was a useful tool for detecting retinal pathology, particularly changes in ELM and IS/OS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig 1
Fig 2
Fig 3

Similar content being viewed by others

References

  1. Ashworth JL, Biswas S, Wraith E, Lloyd IC (2006) Mucopolysaccharidoses and the eye. Surv Ophthalmol 51(1):1–17. doi:10.1016/j.survophthal.2005.11.007

    Article  PubMed  Google Scholar 

  2. Dangel ME, Tsou BH (1985) Retinal involvement in Morquio’s syndrome (MPS IV). Ann Ophthalmol 17(6):349–354

    CAS  PubMed  Google Scholar 

  3. Fahnehjelm KT, Tornquist AL, Winiarski J (2012) Ocular axial length and corneal refraction in children with mucopolysaccharidosis (MPS I-Hurler). Acta Ophthalmol 90(3):287–290. doi:10.1111/j.1755-3768.2010.01934.x

    Article  PubMed  Google Scholar 

  4. Kottler U, Demir D, Schmidtmann I, Beck M, Pitz S (2010) Central corneal thickness in mucopolysaccharidosis II and VI. Cornea 29(3):260–262. doi:10.1097/ICO.0b013e3181b55cc1

    Article  PubMed  Google Scholar 

  5. Schumacher RG, Brzezinska R, Schulze-Frenking G, Pitz S (2008) Sonographic ocular findings in patients with mucopolysaccharidoses I, II and VI. Pediatr Radiol 38(5):543–550. doi:10.1007/s00247-008-0788-y

    Article  PubMed  Google Scholar 

  6. Laver NM, Friedlander MH, McLean IW (1998) Mild form of Maroteaux-Lamy syndrome: corneal histopathology and ultrastructure. Cornea 17(6):664–668

    Article  CAS  PubMed  Google Scholar 

  7. Schwartz MF, Werblin TP, Green WR (1985) Occurrence of mucopolysaccharide in corneal grafts in the Maroteaux-Lamy syndrome. Cornea 4(1):58–66

    Article  PubMed  Google Scholar 

  8. Varssano D, Cohen EJ, Nelson LB, Eagle RC Jr (1997) Corneal transplantation in Maroteaux-Lamy syndrome. Arch Ophthalmol 115(3):428–429

    Article  CAS  PubMed  Google Scholar 

  9. McDonnell JM, Green WR, Maumenee IH (1985) Ocular histopathology of systemic mucopolysaccharidosis, type II-A (Hunter syndrome, severe). Ophthalmology 92(12):1772–1779

    Article  CAS  PubMed  Google Scholar 

  10. Lazarus HS, Sly WS, Kyle JW, Hageman GS (1993) Photoreceptor degeneration and altered distribution of interphotoreceptor matrix proteoglycans in the mucopolysaccharidosis VII mouse. Exp Eye Res 56(5):531–541. doi:10.1006/exer.1993.1067

    Article  CAS  PubMed  Google Scholar 

  11. Forooghian F, Cukras C, Meyerle CB, Chew EY, Wong WT (2008) Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. Invest Ophthalmol Vis Sci 49(10):4290–4296. doi:10.1167/iovs. 08-2113

    Article  PubMed Central  PubMed  Google Scholar 

  12. Fahnehjelm KT, Ashworth JL, Pitz S, Olsson M, Tornquist AL, Lindahl P, Summers CG (2012) Clinical guidelines for diagnosing and managing ocular manifestations in children with mucopolysaccharidosis. Acta Ophthalmol 90(7):595–602. doi:10.1111/j.1755-3768.2011.02280.x

    Article  PubMed  Google Scholar 

  13. Summers CG, Ashworth JL (2011) Ocular manifestations as key features for diagnosing mucopolysaccharidoses. Rheumatology (Oxford) 50(Suppl 5):v34–v40. doi:10.1093/rheumatology/ker392

    Article  Google Scholar 

  14. Clark SJ, Keenan TD, Fielder HL, Collinson LJ, Holley RJ, Merry CL, van Kuppevelt TH, Day AJ, Bishop PN (2011) Mapping the differential distribution of glycosaminoglycans in the adult human retina, choroid, and sclera. Invest Ophthalmol Vis Sci 52(9):6511–6521. doi:10.1167/iovs. 11-7909

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Liang F, Audo I, Sahel JA, Paques M (2013) Retinal degeneration in mucopolysaccharidose type II. Graefes Arch Clin Exp Ophthalmol 251(7):1871–1872. doi:10.1007/s00417-012-2215-1

    Article  CAS  PubMed  Google Scholar 

  16. Yoon MK, Chen RW, Hedges TR 3rd, Srinivasan VJ, Gorczynska I, Fujimoto JG, Wojtkowski M, Schuman JS, Duker JS (2007) High-speed, ultrahigh resolution optical coherence tomography of the retina in Hunter syndrome. Ophthalmic Surg Lasers Imaging 38(5):423–428

    PubMed Central  PubMed  Google Scholar 

  17. Omri S, Omri B, Savoldelli M, Jonet L, Thillaye-Goldenberg B, Thuret G, Gain P, Jeanny JC, Crisanti P, Behar-Cohen F (2010) The outer limiting membrane (OLM) revisited: clinical implications. Clin Ophthalmol 4:183–195

    PubMed Central  CAS  PubMed  Google Scholar 

  18. Pearson RA, Barber AC, West EL, MacLaren RE, Duran Y, Bainbridge JW, Sowden JC, Ali RR (2010) Targeted disruption of outer limiting membrane junctional proteins (Crb1 and ZO-1) increases integration of transplanted photoreceptor precursors into the adult wild-type and degenerating retina. Cell Transplant 19(4):487–503. doi:10.3727/096368909X486057

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Del Debbio CB, Balasubramanian S, Parameswaran S, Chaudhuri A, Qiu F, Ahmad I (2010) Notch and Wnt signaling mediated rod photoreceptor regeneration by Muller cells in adult mammalian retina. PLoS One 5(8):e12425. doi:10.1371/journal.pone.0012425

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have no conflicts of interest to declare for this submission. No external financial support was received for this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sei Yeul Oh.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seok, S., Lyu, I.J., Park, K.A. et al. Spectral domain optical coherence tomography imaging of mucopolysaccharidoses I, II, and VI A. Graefes Arch Clin Exp Ophthalmol 253, 2111–2119 (2015). https://doi.org/10.1007/s00417-015-2953-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-015-2953-y

Keywords

Navigation